2.24
-0.01(-0.44%)
Currency In USD
| Previous Close | 2.25 |
| Open | 2.3 |
| Day High | 2.31 |
| Day Low | 2.21 |
| 52-Week High | 9.47 |
| 52-Week Low | 1.27 |
| Volume | 26,721 |
| Average Volume | 366,268 |
| Market Cap | 7.18M |
| PE | -3.25 |
| EPS | -0.69 |
| Moving Average 50 Days | 2.46 |
| Moving Average 200 Days | 2.86 |
| Change | -0.01 |
If you invested $1000 in Cyclerion Therapeutics, Inc. (CYCN) since IPO date, it would be worth $8.96 as of October 19, 2025 at a share price of $2.24. Whereas If you bought $1000 worth of Cyclerion Therapeutics, Inc. (CYCN) shares 5 years ago, it would be worth $41.03 as of October 19, 2025 at a share price of $2.24.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company
GlobeNewswire Inc.
Sep 23, 2025 8:01 PM GMT
– Cyclerion Relaunches, Advancing a Phase 2–Ready Program for Millions Living with Treatment-Resistant Depression Through MIT License Agreement – – Webcast to be held September 24, 2025 at 10:30 a.m. ET – CAMBRIDGE, Mass., Sept. 23, 2025 (GLOBE NEW
Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth
GlobeNewswire Inc.
Dec 17, 2024 1:08 PM GMT
Cyclerion Has Renegotiated Praliciguat License Agreement to Obtain Upfront and Near-Term Payments as well as Entered into a License Option Agreement for OlinciguatCAMBRIDGE, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nas